CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.
NCT02752243
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Myelodysplastic Syndromes
Acute Leukemia
Interventions
DRUG:
CIK-Cells
Sponsor
Peter Bader